AsiaIPEX is a one-stop-shop for players in the IP industry, facilitating IP trade and connection to the IP world. Whether you are a patent owner interested in selling your IP, or a manufacturer looking to buy technologies to upgrade your operation, you will find the portal a useful resource.

Back to search results

Regulation of the vaginal microbiome reduces rate of HIV infection

Summary: This technology is a combination of vaccines, probiotics, and antibiotics that regulate the vaginal microbiome to reduce the infection rate of human immunodeficiency virus (HIV) and other sexually transmitted infections (STIs).

Technology Benefits: Cost-effective prevention of HIV infectionAlso reduces risk of infection with other STIs

Technology Application: Preventative vaccine to reduce HIV infection risk Antibiotics for prevention of HIV and STIsVaginal probiotics to maintain a healthy bacterial microbiome

Detailed Technology Description: None

*Abstract: None

*Inquiry: Ron KatzColumbia Technology VenturesTel: (212) 854-8444Email: TechTransfer@columbia.edu

*IR: CU17009

*Principal Investigator

*Publications: Masson L, Passmore JA, Liebenberg LJ, Werner L, Baxter C, Arnold KB, Williamson C, Little F, Mansoor LE, Naranbhai V, Lauffenburger DA, Ronacher K, Walzl G, Garrett NJ, Williams BL, Couto-Rodriguez M, Hornig M, Lipkin WI, Grobler A, Abdool Karim Q, Abdool Karim SS. “Genital inflammation and the risk of HIV acquisition in women.” Clin Infect Dis. 2015 Jul 15;61(2):260-9.Tech Ventures Reference:IR CU17009Licensing Contact: Ron Katz

Country/Region: USA

For more information, please click Here